MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Phase 2
Completed
Conditions
Epilepsy
Epilepsies, Partial
Seizures
First Posted Date
2005-10-12
Last Posted Date
2011-06-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
60
Registration Number
NCT00236847

A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome

Phase 3
Completed
Conditions
Epilepsy
Seizures
First Posted Date
2005-10-12
Last Posted Date
2011-06-03
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
100
Registration Number
NCT00236756

A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

Phase 3
Completed
Conditions
Migraine
Common Migraine
Classic Migraine
Headache
First Posted Date
2005-10-12
Last Posted Date
2010-11-19
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
786
Registration Number
NCT00236561

A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

Phase 3
Completed
Conditions
Migraine
Common Migraine
Classic Migraine
Headache
First Posted Date
2005-10-12
Last Posted Date
2010-11-17
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
763
Registration Number
NCT00236509

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Phase 3
Completed
Conditions
Epilepsy
Epilepsies, Partial
Epilepsy, Generalized
Seizures
First Posted Date
2005-10-12
Last Posted Date
2010-04-28
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
49
Registration Number
NCT00236886

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Phase 3
Completed
Conditions
Obesity
First Posted Date
2005-10-12
Last Posted Date
2010-04-28
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
1293
Registration Number
NCT00236639

A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

Phase 3
Completed
Conditions
Obesity
Hypertension
First Posted Date
2005-10-12
Last Posted Date
2010-04-28
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
531
Registration Number
NCT00236665

A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

Phase 3
Completed
Conditions
Obesity
First Posted Date
2005-10-12
Last Posted Date
2010-04-28
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
561
Registration Number
NCT00236600

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Phase 2
Completed
Conditions
Obesity
First Posted Date
2005-10-12
Last Posted Date
2010-12-03
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
385
Registration Number
NCT00236613

A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn Ligament

Phase 3
Completed
Conditions
Sprains and Strains
Pain
First Posted Date
2005-10-12
Last Posted Date
2011-06-10
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
603
Registration Number
NCT00236535
© Copyright 2025. All Rights Reserved by MedPath